This is a significant milestone for both organizations. The pioneering field of uterus transplantation offers many challenges to those involved, and, as with all TTS Sections, TTS is committed to providing ISUTx the support it needs to address these challenges, while gaining expertise and insight in a critical field which has been underrepresented in TTS.
We believe that this partnership will be mutually beneficial to both Societies, and we look forward to collaborating on various projects, meetings and initiatives. We eagerly anticipate working together to share knowledge and experiences to benefit the members of both Societies. Over the coming months, we will explore opportunities and elaborate plans to create synergies between our Societies. This partnership is an exciting opportunity for all of us, and we look forward to our growing collaboration.
If you would like to know more about the Section, please reach out to Katie Tait, our Section Manager at TTS (firstname.lastname@example.org).
For more information on becoming a member of ISUTx, please contact Jennifer Varga, TTS Membership Coordinator (email@example.com).
The July issue of Transplantation Direct is online. We have a number of articles related to kidney transplantation, including an analysis of how different types of allograft inflammation (biopsy) influence outcome, and on how induction therapy choice effects outcomes based on recipient age. Donor tubular cell loss is evaluated as a predictor of DGF, and combined urine microRNA and chemokine profiling is used to determine transplant rejection. There is a report on the reliability of interrater scoring of Karnofsky Performance Status (frailty) in waitlisted patients, and on a comprehensive characterization of cholesterol embolization syndrome as a cause of transplant failure. On the topic of COVID-19, there is an interesting survey supported by the National Kidney Foundation on attitudes of U.S. kidney transplant recipients regarding SARS-Cov-2 vaccination. Turning to other organ transplants, machine perfusion is tested in a combined human liver and lung transplant using organs from a DCD donor, and experimentally, whole blood is used in a pig DCD model studying particularly effects on the metabolic profile. Also in liver transplantation, there is an investigation of root causes of death in cases of portopulmonary hypertension, and results from a prospective randomized trial looking at the effects of everolimus on kidney function are presented. Another study reports on how HLA-DR matching and immunosuppression choice in patients of the Black race are associated with recurrence of autoimmune hepatitis post-liver transplantation. Encouraging results are also presented on liver transplant recipients co-infected with HIV and HCV in the current era of DAA therapy. Please visit our open access Transplantation Direct website for full details.
Washington, DC (July 1, 2021) – Matthew Cooper, M.D., FACS, Director of Kidney and Pancreas Transplantation at MedStar Georgetown Transplant Institute at MedStar Georgetown University Hospital today begins his term as president of the United Network for Organ Sharing (UNOS) Board of Directors. UNOS is the mission-driven nonprofit serving as the nation’s transplant system. Last year the national transplant system set a record for the most lives saved by deceased organ donors.
“During the ongoing global health emergency, we are reminded again and again just how important organ donation and transplantation are to patients, families, and communities,” said Dr. Cooper. “I am eager to work alongside the UNOS board, colleagues, physicians, policymakers and members of the community to improve and expand equitable access to this lifesaving care.”
Since 2004, Dr. Cooper has been closely involved with UNOS, serving as a representative on the Living Donor Committee, and later as Vice Chair and then Chair of that committee. In 2012, he began a 2-year period of elected service on the UNOS Board. He has served on the inaugural Kidney Paired Donation (KPD) subcommittee, the Policy Oversight Committee, the Membership and Professional Affairs Committee and as co-chair of the Ad-hoc Systems Performance Workgroup, among other roles.
“We are excited to have Dr. Cooper as the new president of the UNOS Board of Directors,” said UNOS CEO Brian Shepard. “His record of service to the transplant community, innovative work at the Medstar Georgetown Transplant Institute, and ongoing advocacy for patients will help move UNOS and the donation and transplant community forward over the coming year.”
Dr. Cooper has devoted his career to advancing the field of organ transplant and to advocating for transplant patients and those in need of transplant. In addition to his service to UNOS, his leadership has included elected and volunteer positions with other leading transplant organizations, including the National Kidney Foundation(board member), Donate Life America (board member), The American Foundation for Donation and Transplant (president), and the American Society of Transplant Surgeons (councilor).
At MedStar Health, the Washington, DC region’s leading health care system, Dr. Cooper has led the kidney and pancreas transplant program at the MedStar Georgetown Transplant Institute since 2012. He has guided the program to national prominence, developing it into what is now the leading kidney transplant program in the Washington, DC region. Under his leadership, the program is among the top 10 highest volume centers for kidney transplants and the second largest paired kidney exchange program (through the National Kidney Registry) in the country; and is among the top three programs by volume for pancreas. In addition, Dr. Cooper provided critical testimony before the Subcommittee on Health of the Committee on Energy and Commerce in support of H.R. 5534 regarding the “Comprehensive Immunosuppressive Drug Coverage for the Kidney Transplant Patient’s Act” during the hearing on Legislation to Improve American’s Health Care Coverage and Outcomes. The legislation, which ensures life-long coverage for lifesaving immunosuppressants for transplant patients, became law in 2021.
Dr. Cooper received his medical degree from the Georgetown University School of Medicine in 1994, where he also currently Professor of Surgery. He completed his general surgery training at the Medical College of Wisconsin, followed by a fellowship in multi-organ abdominal transplantation in 2002 at the Johns Hopkins Hospital in Baltimore, Maryland. After director positions at both Johns Hopkins Hospital and the University of Maryland, he assumed his current role in Washington, DC in 2012.
TTS and WIT are hosting two networking discussion sessions lead by TTS Education Committee Members and WIT Members. Clips from the documentary will be shown and discussed as well as key themes that came out of the movie.
Registrants will have the ability to ask questions and interact with each other. Whether you will be joining for your morning coffee or pre/post dinner drinks, the session will be lively and interactive. Even if you are unable to watch the movie prior to the session, you are encouraged to register and join.
In this newsletter we highlight recent awards & achievements of DICG current and past leadership, a publication co-authored by a member of the DICG council, current events as well as other important topics.
And, in case you missed it in April, 2021 we launched the DICG Course on Ethical Issues in Transplantation and The Declaration of Istanbul.
In this second ‘Journal Watch’ Newsletter, we highlight eight recent publications in deceased organ donation of special interest to the donation
The Transplantation Society
740 Notre-Dame Ouest
Montréal, QC, H3C 3X6